Veterinary Drug Bioequivalence Testing Partner

MULTIPLE TESTING & SAMPLES

LONG TERM

BUDGET APPROVED ($50,000-$100,000)

We are developing a suite of generic veterinary drug applications for submission to the FDA-CVM. Our plan is to avoid animal testing by demonstrating bioequivalence via in vitro dissolution testing to USP (apparatus 2)– this is common in veterinary oral pastes and oral suspensions. We have several pilot batches manufactured of at least two different generic formulae. We need a USA laboratory to support our testing and data needs.